Clario is excited to share that our SVP General Counsel, Lauren Misztal, will speak at the Women Leaders in Life Sciences Law Summit on July 26. She'll join a session titled, "Harnessing Generative AI in Business Operations and Legal Practice." The panel will cover topics including: -How life sciences companies and law firms are using generative AI for legal research, contract drafting, patent analysis, and more. -Ethical considerations of generative AI, such as bias, fairness, and accountability. -Successful integration of generative AI into legal and business practices. ➡️ Don't miss this insightful discussion! Find more information here: https://hubs.li/Q02H5lKp0 American Conference Institute #womeninlaw #womeninscience
Clario
Biotechnology Research
Philadelphia, Pennsylvania 96,954 followers
Transforming Lives by Unlocking Better Evidence | Decentralized clinical trials | Broadest endpoint technology
About us
Clario is a leading healthcare research and technology company that generates high quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported clinical trials over 26,000 times in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2019. For more information, visit Clario.com
- Website
-
https://clario.com/
External link for Clario
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Philadelphia, Pennsylvania
- Type
- Privately Held
- Founded
- 1972
- Specialties
- Cardiac Solutions, Medical Imaging, eCOA, Respiratory Solutions, Precision Motion, Specialty Solutions, Clinical Adjudication, and Artificial Intelligence
Locations
Employees at Clario
Updates
-
At Clario, we're always looking for the best talent to help us transform lives. That's where our talent acquisition team comes in! Our team in Hungary, Germany, the UK, China, and Japan is on the hunt for job seekers who are committed to making a difference. Is that you? If so, check out Matthew Stedman's post below. 👇
Friday Fun in the EMEA-APAC TA Coffee Club, absolutely love this team and their ongoing achievements in hiring top talent here at Clario 🚀 The team have fantastic career opportunities available in #hungary #germany #uk #china and #japan You can search for your next opportunity with us by jumping over to our careers page: https://lnkd.in/ek8yEP47 Alternatively connect with Nathalie Fischer Sebastian Braun Ágnes Schwarzenberger Tünde Sztojov and introduce yourself to the team 👋🏽 At Clario, we put people first, always. We are united and driven by patients, committed to making a difference, and we are always looking for the best talent, to help us transform lives. #clinicalresearch #clinicaltrials #pharma #biotech #funfriday #talentacquisition #hiring #jobs #careers #technology
-
-
Our EVP & Chief Medical Officer, Todd Rudo, M.D. has been invited to participate in a September webinar hosted by Dr. Vince Clinical Research, "Accelerating Clinical & Drug Development Timelines with AI." He and other industry experts will delve into how AI is transforming clinical project management, revolutionizing research outputs, and speeding up drug discovery. Secure a spot for the webinar now. Use the link in the post below to register ⬇
𝗘𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿: “Accelerating Clinical & Drug Development Timelines with AI”. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄! 👉 https://bit.ly/3L8H0MQ Master AI to propel drug development to new levels of efficiency and innovation. Join our upcoming webinar to: ✅ 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 how AI can be used to accelerate drug discovery, setting new benchmarks for the industry. ✅𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗲 AI to expedite downstream data tabulation and analysis to support broader CRO functions. ✅𝗟𝗲𝗮𝗿𝗻 how to responsibly advance the use of AI in clinical trials and bring value to digital endpoint collection. ✅𝗘𝘅𝗽𝗹𝗼𝗿𝗲 real-world applications and best practices for integrating AI into your project management strategy. Dr. Vince Clinical Research | Enveda Biosciences | Clario | Fierce Biotech #ArtificialIntelligence #AI #BioPharma #BioTech #MachineLearning #Technology #DataScience #ComputerScience #Data #DataAnalytics #DVCR #Clario #DrugDevelopment #ClinicalDevelopment
-
-
Attending #AAIC24? Discover the latest Alzheimer’s disease research presented by the Clario science team at this year's AAIC conference. Don't miss this opportunity to get informed and explore groundbreaking findings that could bring new hope in the fight against Alzheimer’s disease. From the latest advancements in imaging techniques, to understanding industry trends in eCOA assessments, there is much to learn! Join the Clario team's poster sessions for the latest in cutting-edge research! Find out more information here: https://hubs.li/Q02GCY9_0 We hope to see you there! Alzheimer's Association®
-
-
The European Union AI Act has just been published! For more insights on this significant development in #AI regulation, check out this post by our Chief AI Officer, Marko Topalovic. ⬇
Chief AI Officer @ Clario | Harnessing artificial intelligence and machine learning to transform clinical trial endpoint analysis and the sponsor experience
It’s official! The European Union AI Act has just been published. It marks a significant development in the regulation of artificial intelligence technologies. This legislation aims to set comprehensive standards for the ethical and responsible deployment of AI, addressing several critical areas. At Clario, we are taking all aspects of #AI very seriously. Compliance with any regulation, including the new AI Act, is of utmost importance to us. We are committed to ensuring all our AI technologies adhere to these standards, fostering a trustworthy and reliable environment for patients and study sponsors. As a reminder, key elements of the AI Act: - Risk-based approach: Obligations for providers and users are laid out depending on the AI system’s level of risk. - Transparency and Accountability: The Act requires clear guidelines to ensure transparency in AI systems, enabling users to understand the basis of AI-driven decisions. - Ethical Considerations: Emphasizes the importance of ethical AI development, focusing on fairness, mitigation of biases, and respect for human rights. - Safety and Security: Robust measures are introduced to manage risks, enhance cybersecurity, and prevent the misuse of AI technologies. The AI Act is a crucial step in ensuring that AI technologies are developed and utilized responsibly. Even though regulation is seen as a bottleneck to innovation, I believe in the opposite. It will help us to safeguard high-quality innovation, especially in sensitive industries such as healthcare and life science where we are involved daily and it will help sustain the credibility and trustworthiness of all upcoming AI breakthroughs. I am looking forward to seeing the collaborative work of all stakeholders across sectors in implementing these guidelines. Special thanks to the amazing team at Clario who is ensuring the right governance of #AI Tancredi Vergani, Lauren Misztal, Todd Rudo, Gaurav Josan and Jay Ferro. How do you see the new Act impacting the future of AI development? https://lnkd.in/e4eWDAxb
-
The integration of efficacy, safety, and quality of life data maximizes the overall value of a clinical trial, enabling an inclusive assessment of benefits and risks, and ensuring that novel cancer therapies meet patients’ needs holistically. That’s the argument made in an article by Clario's Chief Medical Officer, Todd Rudo, M.D.; Chief Science and Regulatory Advisor-Cardiology, Robert B. Kleiman MD, M.D.; and Director of eCOA Science, Kelly Dumais, Ph. D. Check out the article for their guidance on how to design oncology trials for a comprehensive understanding of the therapeutic impact and patient quality of life in the development of new oncology drugs. ➡️ https://hubs.li/Q02GbGmt0 #clinicaltrials #oncology #drugdevelopment
-
-
Last call to register! 📣 Secure your spot today for our webinar: “Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility and Advanced AI-driven Analysis.” Join Clario's experts Todd Rudo, Amit Vasanji, and Kelly Dumais as they explore strategies to enhance patient access and precision analysis using artificial intelligence (AI) in ophthalmology clinical trials. They will delve into vendor-agnostic, multi-modality platforms, AI-enabled workflows, and best practices for eCOA implementation in various trial settings. ➡️ Register here: https://hubs.li/Q02G10d70 #AI #artificialintelligence #clinicaltrials
-
Interested in new frontiers in respiratory clinical trials? 👇 Check out our free on-demand webinar! In this video, Clario's new SVP and Chief AI Officer, Marko Topalovic; Director of Scientific Affairs, Kevin McCarthy; and Senior Director of Respiratory Solutions, Philip Lake, Ph. D., discuss: - Cutting-edge AI-driven approaches to spirometry data analysis, revolutionizing at-home testing with instant feedback and heightened efficacy. - Virtual integration of clinicians into participants' homes, ensuring top-notch data quality and engaging participant experiences. - Remote monitoring of lung sounds and their significant impact on respiratory endpoints within clinical trials. - Explore alternative respiratory endpoints that surpass traditional spirometry, providing greater flexibility and a more comprehensive assessment of lung health. ▶️ Watch now and stay ahead in respiratory research! https://hubs.li/Q02FPVsC0 #spirometry #respiratorycare #clinicaltrials #artificialintelligence
-
-
Clario is excited to share that our Chief Information, Technology & Product Officer, Jay Ferro, has been invited to share his expertise in an Executive Fireside Chat at the HMG Strategy Annual Philadelphia C-Level Technology Leadership Summit. If you'll be in Philadelphia on August 15, don't miss this insightful event!
We are excited to announce the 9th Annual Philadelphia C-Level Technology Leadership Summit on August 15, 2024, at the Philadelphia Country Club! Join us for an Executive Fireside Chat with Jay Ferro, EVP, Chief Information & Technology Officer at Clario. This summit promises a day of engaging discussions and valuable networking opportunities with top technology leaders. Register Here: https://lnkd.in/eE5uV_x8 #TechSummit #Leadership #CyberSecurity #Networking #HMGStrategy
-
-
Clario’s Director of eCOA Science Kelly Dumais, Ph. D., will take part in the Critical Path Institute (C-Path)’s next webinar: BYOD, A Guide for Successful Implementation. Don’t miss this comprehensive discussion about optimizing Bring Your Own Device (BYOD) approaches to eCOA in clinical trials. 👇 #clinicaltrials #eCOA
JOIN US Tuesday, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD) approaches to electronic clinical outcome assessment data collection in clinical trials, developed and presented by members of the BYOD Project Team as part of the eCOA Consortium and PRO Consortium’s eCOA: Getting Better Together Initiative. Register now: https://lnkd.in/gW6gzAU7 Karl McEvoy Kelly Dumais Chris Barden Heather Romero Scottie Kern eCOA members, include: ActiGraph Evinova Clario ICON plc Inspired Health IQVIA Kayentis Koneksa Mapi Research Trust Medable, Inc Medidata Solutions Medrio ObvioHealth Parexel Red Nucleus RWS Group Signant Health Suvoda TransPerfect Life Sciences uMotif WCG YPrime #CPath #eCOA #DHT #ACT #eCOAC #globalhealth #collaboration #drugdevelopment #datasharing #clinicaltrials
-